LOGIN  |  REGISTER
Amneal Pharmaceuticals
Recursion

Humana Names Japan Mehta as Chief Information Officer

December 20, 2024 | Last Trade: US$247.10 11.32 4.80

LOUISVILLE, Ky. / Dec 20, 2024 / Business Wire / Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has named Japan Mehta as Chief Information Officer. In this role, Mehta will oversee Humana’s digital and technology organization, as well as its data systems. He will also set the technology transformation vision for the company to better connect consumers to their caregivers and enable better clinical decision making, while also driving greater efficiencies through technology modernization. Mehta will assume the role in the first quarter of 2025.

“Japan is deeply passionate about the revolutionary power of technology and the value to be gained from data-driven insights,” said Jim Rechtin, Humana President and CEO. “I am excited for the experience, expertise and leadership he brings to Humana as we transform our organization to make technology easier to use for our members, patients and teams.”

Mehta succeeds Sam Deshpande, who had previously announced his intention to retire at the end of 2024. Upon his retirement, Deshpande will transition to an IT advisory role to support Mehta’s onboarding.

Mehta brings more than two decades of experience leading technology teams in large-scale, regulated industries focused on delivering customer-centric solutions. He joins Humana from Citi, where he recently served as Chief Data Officer, leading efforts to transform data quality and governance across the organization. Previously, he held the role of CIO for Citi Global Wealth across a mix of client segments. Additionally, he served in the CIO role for Global Consumer Technology in Asia Pacific and Europe. Prior to Citi, Japan held technology and digital leadership roles at JP Morgan, Barclays and Verizon.

Mehta holds a Bachelor of Engineering in Electronics and Communication from Gujarat University, Dharamsinh Desai Institute of Technology, India, and a Master of Science in Industrial Engineering from the University of Wisconsin. He holds 35 patents, with more than 20 granted, across technology, digital platforms, mobile, media and entertainment.

About Humana

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

Chimerix

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB